Therapeutics News and Research

RSS
Predictive power of Champions Biotechnology's Biomerk Tumorgraft platform to be presented

Predictive power of Champions Biotechnology's Biomerk Tumorgraft platform to be presented

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Review of Mersana Therapeutics's lead compound, XMT-1001 to be published

Review of Mersana Therapeutics's lead compound, XMT-1001 to be published

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

Stapled Peptides directly inhibit the Notch transcription factor complex

Stapled Peptides directly inhibit the Notch transcription factor complex

Updated efficacy results from Allos Therapeutics' FOLOTYN study to be presented at the ASH meeting

Updated efficacy results from Allos Therapeutics' FOLOTYN study to be presented at the ASH meeting

Stapled Peptides can inhibit key intracellular biological targets, says new research

Stapled Peptides can inhibit key intracellular biological targets, says new research

Data from Phase IIa clinical trial evaluating VT-111 to be presented by Viron Therapeutics at AHA conference

Data from Phase IIa clinical trial evaluating VT-111 to be presented by Viron Therapeutics at AHA conference

Study: Mouse gene uncovers new strategy for treating Alzheimer's disease

Study: Mouse gene uncovers new strategy for treating Alzheimer's disease

Envoy Therapeutics secures loan from Takeda Research Investment

Envoy Therapeutics secures loan from Takeda Research Investment

AMT's gene therapy successful in treating Duchenne muscular dystrophy

AMT's gene therapy successful in treating Duchenne muscular dystrophy

Poniard Pharmaceuticals to present picoplatin Phase 2 trial data at the AACR-NCI -EORTC conference

Poniard Pharmaceuticals to present picoplatin Phase 2 trial data at the AACR-NCI -EORTC conference

Allos Therapeutics awards NCCN a grant to evaluate pralatrexate

Allos Therapeutics awards NCCN a grant to evaluate pralatrexate

Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC

Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC

Aduro BioTech raises funds through its Series A-1 financing

Aduro BioTech raises funds through its Series A-1 financing

ImmunoGen to present IMGN901 clinical data at AACR-NCI-EORTC International Conference

ImmunoGen to present IMGN901 clinical data at AACR-NCI-EORTC International Conference

Health information technology's 11% combined annual growth rate to continue through 2013: Scientia Advisors

Health information technology's 11% combined annual growth rate to continue through 2013: Scientia Advisors

Enavail obtains an exclusive license for a portfolio of particle engineering technologies

Enavail obtains an exclusive license for a portfolio of particle engineering technologies

Dark side of compulsive eating

Dark side of compulsive eating

JumpStart announces investment commitment of $250,000 in Checkpoint Surgical

JumpStart announces investment commitment of $250,000 in Checkpoint Surgical

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.